We are live on ! Find out more
MIG

McGuire Investment Group Portfolio holdings

AUM $1.14B
1-Year Est. Return 79.59%
This Fund
S&P 500
This Quarter Est. Return
+10.14%
1 Year Est. Return
+79.59%
3 Year Est. Return
+184.19%
5 Year Est. Return
+218.18%
10 Year Est. Return
AUM
$527M
AUM Growth
+$53M
Cap. Flow
+$8.1M
Cap. Flow %
1.54%
Top 10 Hldgs %
39.01%
Holding
119
New
10
Increased
34
Reduced
55
Closed
3

Top Sells

Rank Stock Value
1
ALT icon
Altimmune
ALT
+$2.73M
2
CBOE icon
Cboe Global Markets
CBOE
+$950K
3
BIIB icon
Biogen
BIIB
+$503K
4
AAPL icon
Apple
AAPL
+$476K
5
FDX icon
FedEx
FDX
+$431K

Sector Composition

Rank Sector Weight
1 Technology 29.13%
2 Healthcare 26.74%
3 Financials 10.23%
4 Industrials 4.1%
5 Consumer Staples 2.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLNX
1
DELISTED
Xilinx Inc
XLNX
$25.9M 4.92%
179,215
-1,389
-0.8% -$177K
LRCX icon
2
Lam Research
LRCX
$383B
$25.4M 4.82%
390,700
-6,670
-2% -$421K
QCOM icon
3
Qualcomm
QCOM
$168B
$24.7M 4.68%
172,490
-2,840
-2% -$384K
AMAT icon
4
Applied Materials
AMAT
$419B
$22.4M 4.26%
157,507
-2,260
-1% -$303K
IQV icon
5
IQVIA
IQV
$38.3B
$21.7M 4.11%
89,454
-1,072
-1% -$248K
XBI icon
6
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$20M 3.8%
147,974
+16,695
+13% +$2.19M
AAPL icon
7
Apple
AAPL
$4.56T
$18.1M 3.44%
132,174
-3,675
-3% -$476K
TMO icon
8
Thermo Fisher Scientific
TMO
$214B
$16.2M 3.08%
32,151
-333
-1% -$157K
ADI icon
9
Analog Devices
ADI
$184B
$15.9M 3.01%
92,124
-178
-0.2% -$28.5K
SYK icon
10
Stryker
SYK
$129B
$15.2M 2.89%
58,633
-627
-1% -$160K
MSFT icon
11
Microsoft
MSFT
$3.71T
$13.7M 2.6%
50,603
-129
-0.3% -$32.8K
CBOE icon
12
Cboe Global Markets
CBOE
$30.2B
$13.2M 2.51%
111,273
-8,656
-7% -$950K
CTLT
13
DELISTED
CATALENT, INC.
CTLT
$13M 2.46%
120,035
+1,326
+1% +$142K
JNJ icon
14
Johnson & Johnson
JNJ
$619B
$11.6M 2.21%
70,714
-811
-1% -$134K
IBB icon
15
iShares Biotechnology ETF
IBB
$9.53B
$10.8M 2.05%
66,040
+1,616
+3% +$249K
MEDP icon
16
Medpace
MEDP
$16.3B
$10.7M 2.03%
60,568
+388
+0.6% +$67K
CME icon
17
CME Group
CME
$95B
$10.5M 1.99%
49,210
-1,042
-2% -$220K
SCHW
18
Charles Schwab
SCHW
$187B
$10.1M 1.92%
139,066
-2,333
-2% -$165K
HOLX
19
DELISTED
Hologic
HOLX
$10M 1.91%
150,570
+577
+0.4% +$38.6K
BLK icon
20
Blackrock
BLK
$175B
$10M 1.91%
11,481
-96
-0.8% -$81.1K
DHR icon
21
Danaher
DHR
$141B
$9.72M 1.85%
40,879
-916
-2% -$203K
NVDA icon
22
NVIDIA
NVDA
$5.3T
$9.21M 1.75%
460,600
+5,640
+1% +$90.4K
XSW icon
23
State Street SPDR S&P Software & Services ETF
XSW
$471M
$9.2M 1.75%
53,627
+1,364
+3% +$222K
ITW icon
24
Illinois Tool Works
ITW
$84.8B
$9.19M 1.74%
41,088
-425
-1% -$97.3K
XSD icon
25
State Street SPDR S&P Semiconductor ETF
XSD
$2.9B
$8.15M 1.55%
42,387
-196
-0.5% -$35.2K

Similar funds

McGuire Investment Group's Q2 2021 Portfolio in Review

As of Q2 2021, McGuire Investment Group held 119 positions worth $527M, up 11% from $474M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

McGuire Investment Group's Q2 2021 filing shows 10 new, 34 increased, 55 reduced and 3 closed positions. Its largest new stake was First Trust NYSE Arca Biotechnology Index Fund: 30,898 shares worth $5.33M. The largest sale was Altimmune, an estimated $2.73M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.

  • McGuire Investment Group's largest Q2 2021 buy was First Trust NYSE Arca Biotechnology Index Fund: 30,898 shares worth $5.33M.
  • McGuire Investment Group added most to State Street SPDR S&P Biotech ETF in Q2 2021, an estimated $2.19M increase.
  • McGuire Investment Group's biggest Q2 2021 reduction was Cboe Global Markets, cutting an estimated $950K.
  • McGuire Investment Group fully exited Altimmune in Q2 2021, selling an estimated $2.73M.
  • McGuire Investment Group's ten largest holdings make up 39% of its $527M portfolio in Q2 2021.
  • McGuire Investment Group opened 10 new positions and closed 3 in Q2 2021.
  • McGuire Investment Group's portfolio value rose 11% quarter-over-quarter to $527M.

Based on McGuire Investment Group's 13F filing for Q2 2021, filed 16 Jul 2021.